Genetic and Epigenetic Changes at Secondary Resistance after Continued Treatment in the Randomized Phase II Study of All-Trans Retinoic Acid (ATRA) and/or Valproic Acid (VPA) Added to Decitabine (DAC) in Newly Diagnosed Elderly AML Patients (DECIDER Trial)

Authors :: Inga Hund
Maria Hess
Julia Stomper
Gabriele Greve
Jan Mitschke
Christoph Niemöller
Tobias Ma
David Uhl
Felicitas R. Thol
Michael Heuser
Gesine Bug
Martina Crysandt
Lutz Peter Mueller
Andreas Neubauer
Justus Duyster
Hartmut Dohner
Melanie Boerries
Heiko Becker
Michael Luebbert
Source :: Blood. 140:3383-3384
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools